Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
61.8M
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
32.1M
-
Shares change
-
+32.1M
-
Total reported value, excl. options
-
$705M
-
Value change
-
+$705M
-
Number of buys
-
48
-
Price
-
$22.70
Significant Holders of Monte Rosa Therapeutics, Inc. - COMMON STOCK (GLUE) as of Q2 2021
48 filings reported holding GLUE - Monte Rosa Therapeutics, Inc. - COMMON STOCK as of Q2 2021.
Monte Rosa Therapeutics, Inc. - COMMON STOCK (GLUE) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 32.1M shares
of 61.8M outstanding shares and own 51.91% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (7.7M shares), FMR LLC (4.31M shares), Avoro Capital Advisors LLC (3.31M shares), Cormorant Asset Management, LP (3.19M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.74M shares), BlackRock Inc. (1.55M shares), Aisling Capital Management LP (1.47M shares), Alphabet Inc. (1.46M shares), RTW INVESTMENTS, LP (1.21M shares), and Casdin Capital, LLC (961K shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.